Rossella Belleli

570 total citations
16 papers, 440 citations indexed

About

Rossella Belleli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Rossella Belleli has authored 16 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Rossella Belleli's work include Lung Cancer Diagnosis and Treatment (4 papers), Bone health and treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Rossella Belleli is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Bone health and treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Rossella Belleli collaborates with scholars based in Switzerland, United States and United Kingdom. Rossella Belleli's co-authors include Markus R. John, Romain Séchaud, Jonathan W. Lowery, Patrick Garnero, Sarah Glover, Richard Eastell, Timothy M. Wright, Eugène McCloskey, Angela J. Rogers and Gian Luca Forni and has published in prestigious journals such as Nature Reviews Drug Discovery, Cancer Research and Statistics in Medicine.

In The Last Decade

Rossella Belleli

16 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rossella Belleli Switzerland 9 166 156 139 130 97 16 440
Jessica Furst United States 5 36 0.2× 134 0.9× 178 1.3× 111 0.9× 182 1.9× 6 354
M O'Brien United States 10 58 0.3× 112 0.7× 118 0.8× 6 0.0× 199 2.1× 12 542
Halil Ateş Türkiye 12 41 0.2× 82 0.5× 90 0.6× 7 0.1× 114 1.2× 31 368
J Barone United States 12 134 0.8× 47 0.3× 208 1.5× 8 0.1× 55 0.6× 14 355
Charles R. Kiefer United States 7 145 0.9× 50 0.3× 111 0.8× 9 0.1× 88 0.9× 13 429
Dániel J. Erdélyi Hungary 16 41 0.2× 203 1.3× 88 0.6× 5 0.0× 199 2.1× 44 649
Clemens Leitgeb Austria 8 178 1.1× 208 1.3× 548 3.9× 2 0.0× 121 1.2× 13 639
Goran Matic Germany 8 39 0.2× 25 0.2× 94 0.7× 9 0.1× 66 0.7× 23 330
Jonathan Tucci United States 10 39 0.2× 98 0.6× 96 0.7× 9 0.1× 100 1.0× 21 413
Linde M. Morsink Netherlands 11 36 0.2× 141 0.9× 168 1.2× 4 0.0× 95 1.0× 24 483

Countries citing papers authored by Rossella Belleli

Since Specialization
Citations

This map shows the geographic impact of Rossella Belleli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossella Belleli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossella Belleli more than expected).

Fields of papers citing papers by Rossella Belleli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rossella Belleli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossella Belleli. The network helps show where Rossella Belleli may publish in the future.

Co-authorship network of co-authors of Rossella Belleli

This figure shows the co-authorship network connecting the top 25 collaborators of Rossella Belleli. A scholar is included among the top collaborators of Rossella Belleli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossella Belleli. Rossella Belleli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Brown, Audrey E., et al.. (2023). Survival and Quality-of-life Outcomes in Early-Stage NSCLC Patients: a Literature Review of Real-World Evidence. PubMed. 12(3). LMT60–LMT60. 6 indexed citations
3.
Abògúnr̀in, Ṣẹ̀yẹ, et al.. (2023). Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC). PharmacoEconomics. 41(11). 1437–1452. 7 indexed citations
4.
5.
6.
Herbst, Roy S., Jacek Jassem, Ṣẹ̀yẹ Abògúnr̀in, et al.. (2021). A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression. Frontiers in Oncology. 11. 676732–676732. 14 indexed citations
7.
Belleli, Rossella, et al.. (2018). A nonparametric method to detect increased frequencies of adverse drug reactions over time. Statistics in Medicine. 37(9). 1491–1514. 1 indexed citations
8.
P., Thy, et al.. (2017). A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA. American Journal of Cardiovascular Drugs. 18(3). 205–211. 15 indexed citations
9.
Belleli, Rossella, Roland Fisch, Didier Renard, Heike Woehling, & Sandro Gsteiger. (2015). Assessing switchability for biosimilar products: modelling approaches applied to children's growth. Pharmaceutical Statistics. 14(4). 341–349. 4 indexed citations
10.
Belleli, Rossella, Roland Fisch, & Thomas D. Szucs. (2015). Efficiency indicators for new drugs approved by the FDA from 2003 to 2013. Nature Reviews Drug Discovery. 14(3). 156–156. 7 indexed citations
11.
John, Markus R., Juergen Loeffler, Rossella Belleli, et al.. (2014). AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women. Bone. 64. 204–210. 32 indexed citations
12.
John, Markus R., Leo Widler, R. Gamse, et al.. (2011). ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone. 49(2). 233–241. 32 indexed citations
13.
Glover, Sarah, Richard Eastell, Eugène McCloskey, et al.. (2009). Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone. 45(6). 1053–1058. 134 indexed citations
14.
Séchaud, Romain, et al.. (2008). Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects. The Journal of Clinical Pharmacology. 48(8). 919–925. 25 indexed citations
15.
Galanello, Renzo, Antonio Piga, Maria Domenica Cappellini, et al.. (2008). Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen. The Journal of Clinical Pharmacology. 48(4). 428–435. 34 indexed citations
16.
Galanello, Renzo, Antonio Piga, Gian Luca Forni, et al.. (2006). Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.. PubMed. 91(10). 1343–51. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Furst Breakdown of academic impact, for papers by M O'Brien Breakdown of academic impact, for papers by Halil Ateş Breakdown of academic impact, for papers by J Barone Breakdown of academic impact, for papers by Charles R. Kiefer Breakdown of academic impact, for papers by Dániel J. Erdélyi Breakdown of academic impact, for papers by Clemens Leitgeb Breakdown of academic impact, for papers by Goran Matic Breakdown of academic impact, for papers by Jonathan Tucci Breakdown of academic impact, for papers by Linde M. Morsink
Rankless by CCL
2026